← FDA Drug Approvals (Drugs@FDA)

AXTLE

NDA · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2024-06-28

Drug application

FDA Application #

NDA210661

Application type

New Drug Application

Brand name

AXTLE

Generic name

PEMETREXED

Active ingredients

PEMETREXED DIPOTASSIUM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AVYXA HOLDINGS

Manufacturer

Avyxa Pharma, LLC

First approval

2024-06-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown